- Filed
- May 14, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 12, 2025 | 34.42M sh |
| Long Term Debt | Q1 2025 · Apr 4, 2025 | $31.4M |
| Long Term Debt | Q1 2025 · Jan 3, 2025 | $9.48M |
| Cash And Equivalents | Q1 2025 · Apr 4, 2025 | $16.3M |
| Cash And Equivalents | Q1 2025 · Jan 3, 2025 | $33.73M |
| Current Liabilities | Q1 2025 · Apr 4, 2025 | $210.42M |
| Current Liabilities | Q1 2025 · Jan 3, 2025 | $230.26M |
| Total Liabilities | Q1 2025 · Apr 4, 2025 | $270.32M |
| Total Liabilities | Q1 2025 · Jan 3, 2025 | $268.54M |
| Current Assets | Q1 2025 · Apr 4, 2025 | $135.76M |
| Current Assets | Q1 2025 · Jan 3, 2025 | $141M |
| Total Assets | Q1 2025 · Apr 4, 2025 | $227.68M |
| Total Assets | Q1 2025 · Jan 3, 2025 | $233.86M |
| Shares Diluted | Q1 2025 · Mar 29, 2024 | 25.56K sh |
| Capex | Q1 2025 · Mar 29, 2024 | $4.62M |
| Operating Cash Flow | Q1 2025 · Mar 29, 2024 | −$34.99M |
| Stockholders Equity | Q1 2025 · Mar 29, 2024 | $38.12M |
| Stockholders Equity | Q1 2025 · Dec 29, 2023 | $70.49M |
| Eps Diluted | Q1 2025 · Mar 29, 2024 | −$1.30 |
| Eps Basic | Q1 2025 · Mar 29, 2024 | −$1.30 |
| Sga Expense restated | Q1 2025 · Mar 29, 2024 | $16.17M |
| Net Income | Q1 2025 · Mar 29, 2024 | −$33.33M |
| Operating Income | Q1 2025 · Mar 29, 2024 | −$31.79M |
| Gross Profit | Q1 2025 · Mar 29, 2024 | −$15.86M |
| Cost Of Revenue | Q1 2025 · Mar 29, 2024 | $135.9M |
| Revenue | Q1 2025 · Mar 29, 2024 | $120.04M |